BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
NHTC
Natural Health Trends Corp.
There isn't enough reported data to score NHTC yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
NHTC Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Strong |
NHTC's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
NHTC PE Valuation
NHTC has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
NHTC Forward outlook
There aren't enough analyst estimates for NHTC to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over NHTC on earnings quality, reporting a profit while its opponent remains loss making.
NHTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.15 | -$0.13 |
| Q2 2026 | -$0.16 | -900% |
| Q1 2026 | -$0.11 | -375% |
| Q4 2025 | -$0.08 | -260% |
| Q3 2025 | -$0.02 | -129% |
| Q2 2025 | $0.02 | -78% |
| Q1 2025 | $0.04 | -20% |
| Q4 2024 | $0.05 | 0% |
NHTC is still losing money, but far less than before: $0.15 per share over the past year, against $0.52 at its worst in late 2019.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over NHTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over NHTC on profitability, with a higher operating margin.
NHTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.6M | -20% |
| Q2 2026 | $7.6M | -23% |
| Q1 2026 | $9.2M | -14% |
| Q4 2025 | $9.7M | -10% |
| Q3 2025 | $9.5M | -11% |
| Q2 2025 | $9.8M | -6.3% |
| Q1 2025 | $10.7M | -2% |
| Q4 2024 | $10.8M | -0.8% |
NHTC's revenue has slid since its 2019 peak: $8M last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.7% | +1.6 points |
| Q2 2026 | -8.5% | -5.1 points |
| Q1 2026 | -5.2% | -1.9 points |
| Q4 2025 | -6.5% | -2.6 points |
| Q3 2025 | -5.2% | -2.6 points |
| Q2 2025 | -3.4% | -1.1 points |
| Q1 2025 | -3.2% | +0.1 points |
| Q4 2024 | -3.9% | -1.7 points |
NHTC's operating margin was −3.7% last quarter, up 1.6 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
NHTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1M | -1670% |
| Q2 2026 | -$1.7M | +$4M |
| Q1 2026 | -$912K | -295% |
| Q4 2025 | -$964K | -1518% |
| Q3 2025 | $70K | +$513K |
| Q2 2025 | -$5.6M | -$2.1M |
| Q1 2025 | $468K | -13% |
| Q4 2024 | $68K | +$151K |
NHTC has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
NHTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -1K shares |
| 1 year | -25% | -2.9M shares |
| 3 years | -25% | -2.9M shares |
| 5 years | -25% | -2.8M shares |
| Available history | -21% | -2.3M shares |
NHTC has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $28,000 |
| Q2 2026 | — |
| Q1 2026 | $5.9M |
| Q4 2020 | — |
| Q3 2020 | — |
| Q4 2019 | $553,000 |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
NHTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -180.3x | Net Cash |
| Q2 2022 | -72.2x | Net Cash |
| Q1 2022 | -64.0x | Net Cash |
| Q4 2021 | -44.8x | Net Cash |
| Q3 2021 | -31.4x | Net Cash |
| Q2 2021 | -30.4x | Net Cash |
NHTC has more cash than debt.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
NHTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 22.2 | Oversold |
| Stochastic | 2.6 | Oversold |
NHTC's weekly RSI is 22 (oversold) and its Stochastic is 3 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
NHTC PE vs Consumer Cyclical Sector
| Metric | NHTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
NHTC has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
NHTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.85 | 14% below |
| 20 week MA | $1.37 | 47% below |
| 50 week MA | $2.35 | 69% below |
| 100 week MA | $3.48 | 79% below |
| 200 week MA | $4.69 | 84% below |
NHTC is in a downtrend: it's below all five of its weekly moving averages, and 84% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over NHTC on returns for 2026, with the stronger performance.
NHTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.38 | $5.15 | -4.3% |
| 2021 | $5.15 | $6.63 | +29% |
| 2022 | $6.63 | $3.57 | -46% |
| 2023 | $3.57 | $5.86 | +64% |
| 2024 | $5.86 | $4.49 | -23% |
| 2025 | $4.49 | $3.32 | -26% |
| 2026 YTD | $3.32 | $0.73 | -78% |
NHTC has finished lower in four of the last six years. It's down 78% so far in 2026.